Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 1186 AL 1200

Sleep and movement disorders

Giannoccaro MP, Antelmi E, Plazzi G.

Curr Opin Neurol. 2013 Aug;26(4):428-34. doi: 10.1097/WCO.0b013e3283632cef.

After the banquet: mitochondrial biogenesis, mitophagy, and cell survival

Zhu J, Wang KZ, Chu CT.

Autophagy. 2013 Nov 1;9(11):1663-76. doi: 10.4161/auto.24135. Epub 2013 May 3.

New aspects in the pathophysiology of rapid eye movement sleep behavior disorder: the potential role of glutamate, gamma-aminobutyric acid, and glycine

Luppi PH, Clément O, Valencia Garcia S, Brischoux F, Fort P.

Sleep Med. 2013 Aug;14(8):714-8. doi: 10.1016/j.sleep.2013.02.004. Epub 2013 Jun 19.

The potential role of dopamine D₃ receptor neurotransmission in cognition

Nakajima S, Gerretsen P, Takeuchi H, Caravaggio F, Chow T, Le Foll B, Mulsant B, Pollock B, Graff-Guerrero A.

Eur Neuropsychopharmacol. 2013 Aug;23(8):799-813. doi: 10.1016/j.euroneuro.2013.05.006. Epub 2013 Jun 20.

Effects of pedunculopontine area and pallidal DBS on gait ignition in Parkinson's disease

Schrader C, Seehaus F, Capelle HH, Windhagen A, Windhagen H, Krauss JK.

Brain Stimul. 2013 Nov;6(6):856-9. doi: 10.1016/j.brs.2013.05.005. Epub 2013 Jun 10.

The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease

Rodriguez-Blazquez C, Rojo-Abuin JM, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG, Martinez-Martin P.

Parkinsonism Relat Disord. 2013 Oct;19(10):889-93. doi: 10.1016/j.parkreldis.2013.05.017. Epub 2013 Jun 19.

Determinants of physical health parameters in individuals with intellectual disability who use long-term antipsychotics

de Kuijper G, Mulder H, Evenhuis H, Scholte F, Visser F, Hoekstra PJ.

Res Dev Disabil. 2013 Sep;34(9):2799-809. doi: 10.1016/j.ridd.2013.05.016. Epub 2013 Jun 20.

Topographic regulation of neuronal intermediate filaments by phosphorylation, role of peptidyl-prolyl isomerase 1: significance in neurodegeneration

Binukumar BK, Shukla V, Amin ND, Reddy P, Skuntz S, Grant P, Pant HC.

Histochem Cell Biol. 2013 Jul;140(1):23-32. doi: 10.1007/s00418-013-1108-7. Epub 2013 Jun 23.

[Progress in neuropathology changes the understanding of neurodegenerative diseases]

Duyckaerts C, Seilhean D.

Rev Prat. 2013 May;63(5):655-61.

Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders

Qiang L, Fujita R, Abeliovich A.

Neuron. 2013 Jun 19;78(6):957-69. doi: 10.1016/j.neuron.2013.06.002.

Case of levodopa toxicity from ingestion of Mucuna gigantea

Tse GG, Kim BB, McMurtray AM, Nakamoto BK.

Hawaii J Med Public Health. 2013 May;72(5):157-60.

Oestrogens as modulators of neuronal signalosomes and brain lipid homeostasis related to protection against neurodegeneration

Marin R, Casañas V, Pérez JA, Fabelo N, Fernandez CE, Diaz M.

J Neuroendocrinol. 2013 Nov;25(11):1104-15. doi: 10.1111/jne.12068.

Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis

D'Amico E, Factor-Litvak P, Santella RM, Mitsumoto H.

Free Radic Biol Med. 2013 Dec;65:509-527. doi: 10.1016/j.freeradbiomed.2013.06.029. Epub 2013 Jun 21.

Targeted delivery of nano-therapeutics for major disorders of the central nervous system

Gao H, Pang Z, Jiang X.

Pharm Res. 2013 Oct;30(10):2485-98. doi: 10.1007/s11095-013-1122-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias